[Hot spot]

8 even board ruineng technology: core technologies and products do not involve hot concepts such as "SRAM chip" and "Sora"

8 even board ruineng technology (603933) released a notice of abnormal stock trading fluctuations on the evening of February 27. the company's core technologies and products do not involve hot concepts such as "SRAM chip" and "Sora. In 2022, the company's industrial automation control products applied to the field of robotics revenue accounted for about 5.9 of the main business revenue of industrial automation control products, accounting for about 0.6 of the company's main business revenue. It is expected that there will be no significant difference in this proportion in 2023. At present, the business is still in the promotion period and has no significant impact on the company's performance.

huayang lianzhong (rights protection): the company's main business has not yet involved Sora business

huayang lianzhong (603825) announced on the evening of February 27 that the company had recently noticed that some media had listed the company as a Sora concept stock, and Sora business was not involved in the company's main business. The company is currently not engaged in the basic research and development of AI technology. The application of AI-related technologies does not have a significant impact on the company's operating performance in the short term, and there is still great uncertainty in the subsequent development.

national pulse culture: Sora business is not involved in the company's main business for the time being

Guomai Culture (600640) announced on the evening of February 27 that the company had recently noticed that some media had listed the company as a Sora concept stock, and Sora business was not involved in the company's main business for the time being.

tianqi shares: at present, industrial humanoid robots have entered the assembly workshop of new energy automobile factory for real-life training

Tianqi shares (002009) issued an announcement on abnormal stock trading fluctuations on the evening of February 27. The industrial humanoid robot business jointly developed by the company and Shenzhen Youbixuan Technology Co., Ltd. has recently received widespread attention in the market. Based on the "Strategic Cooperation Framework Agreement" announced earlier, the company and Shenzhen Youbixuan Technology Co., Ltd. have cooperated to carry out the application and landing of humanoid robots in industrial scenes. At present, industrial humanoid robots have entered the assembly workshop of new energy automobile factories for real-life training, and the application of humanoid robots in the field of automobile manufacturing has been steadily advancing.

Selis: no major changes in company fundamentals

Selis (601127) issued an announcement on abnormal stock trading fluctuations on the evening of February 27, stating that the company's fundamentals have not changed significantly. Except that the company is planning an employee stock ownership plan, there is no major information that should be disclosed but not disclosed.

[M & A]

Henglin shares: plans to purchase 100% of Hengsheng Zhishu shares and carry out server procurement

henglin shares (603661) announced on the evening of February 27 that the company plans to carry out business related to computing services and cultivate new growth businesses of the company. It is proposed to purchase 100 percent of the shares of Hengsheng Smart Calculation with a cash consideration of 0.155 billion yuan (including 1 million yuan for the acquisition of Hengsheng Smart Calculation equity transfer and 0.154 billion yuan for the advance payment of computing server purchase paid by Hengsheng Smart Calculation shareholder Wang Aiqin on behalf of Hengsheng Smart Calculation) and continue to perform its computing server purchase contract with Hengsheng Smart Calculation as the main body. After the equity transfer is completed, the company will also have to pay the final purchase amount of 0.244 billion yuan to Nanjing Kun, the supplier of the computing server. All the above amounts to $0.399 billion.

haic group: intends to adjust the major asset restructuring plan stock suspension

Haiqi group (603069) announced on the evening of February 27 that the company held a meeting of the board of directors, deliberated and passed the proposal on withdrawing the application documents for issuing shares and paying cash to purchase assets and raising supporting funds and related party transactions, and proposed to re submit the application documents, and agreed to withdraw and re submit the application documents. According to the current evaluation situation, the valuation range of the underlying assets of this transaction is 1.8 billion yuan -2.5 billion yuan, and the transaction price adjustment range is more than 20%, which constitutes a major adjustment of the transaction plan. In order to avoid abnormal fluctuations in the company's stock price and safeguard the interests of investors, upon application to the Shanghai Stock Exchange, the company's shares will be suspended from the opening of the market on February 28, 2024 (Wednesday), and the suspension is expected to be no more than 5 trading days.

Refinancing

jifeng technology: it plans to raise no more than 0.122 billion yuan from the actual controller

Jifeng Technology (300022) announced on the evening of February 27 that the company intends to issue shares to the actual controller Wang Huiwu at a price of 3.11 yuan per share to raise no more than 0.122 billion yuan, which will be used to supplement working capital after deducting the issuance expenses.

[increase holdings, repurchase]

gekewei: chairman proposes to buy back shares at 0.15 billion yuan -0.3 billion yuan

Gekewei (688728) announced on the evening of February 27 that Zhao Lixin, the company's actual controller, chairman and CEO, proposed that the company use its own funds to repurchase some of the company's issued RMB ordinary shares (A shares) through centralized bidding transactions. The total amount of funds for the repurchase of shares is not less than 0.15 billion yuan and not more than 0.3 billion yuan. The repurchase of shares is planned to be used for employee stock ownership and/or equity incentive plans at an appropriate time in the future.

Jihua Group: Chairman Proposes Repurchase of Company Shares for 80 million to 0.12 billion Yuan

Jihua Group (603980) announced on the evening of February 27 that Shao Hui, chairman of the company, proposed that the company use its own funds to repurchase shares through centralized bidding transactions. The total amount of funds for the repurchase of shares is 80 million yuan to 0.12 billion yuan. The price of shares does not exceed 5 yuan per share.

shuanglin shares: shares to be repurchased by 30 million yuan -60 million yuan

Shuanglin shares (300100) announced on the evening of February 27 that the company intends to repurchase shares for 30 million yuan to 60 million yuan for employee stock ownership plan or equity incentive plan, and the repurchase price does not exceed 12 yuan per share.

quanxin shares: shares to be repurchased by 30 million yuan -60 million yuan

quanxin shares (300447) announced on the evening of February 27 that the company plans to buy back shares with 30 million yuan to 60 million yuan for employee stock ownership plan or equity incentive. The proposed repurchase price is not higher than 14 yuan/share.

xiamen tungsten new energy: plans to buy back shares from 30 million yuan to 50 million yuan

Xiamen Tungsten New Energy (688778) announced on the evening of February 27 that the company intends to repurchase shares from 30 million yuan to 50 million yuan for employee stock ownership plans or equity incentives, and the repurchase price does not exceed 51 yuan per share.

xingsen technology: shares to be repurchased by 30 million yuan -50 million yuan

Xingsen Technology (002436) announced on the evening of February 27 that the company intends to repurchase shares at 30 million -50 million yuan for equity incentives or employee stock ownership plans, and to convert bonds issued by the company that can be converted into stocks. The repurchase price shall not exceed 16.84 yuan/share.

Yuxin shares: shareholders intend to reduce the company's shares by no more than 1%

Yuxin shares (002986) announced on the evening of February 27 that Zeng Zhenghuan, a 5.24 per cent shareholder of the company, plans to reduce the company's shares by no more than 3.8421 million shares (accounting for no more than 1% of the company's total share capital) through centralized bidding and block trading.

wanlima: qiheng dianjin private equity investment fund plans to reduce its shares by no more than 1%

Wanlima (300591) announced on the evening of February 27 that Shenzhen Qiheng Private Equity Fund Management Co., Ltd., a 5.00 shareholder, Qiheng Dianjin Private Equity Investment Fund, plans to reduce the company's shares by no more than 4.05 million shares (accounting for 1% of the company's total share capital) through centralized bidding within 3 months after 15 trading days.

[Business Data]

Wen's share performance express: loss of 6.329 billion yuan in 2023

Wen's shares (300498) released a performance bulletin on the evening of February 27, achieving total operating income of 89.918 billion billion yuan in 2023, an increase of 7.40 percent over the same period last year; net profit was a loss of 6.329 billion billion yuan, compared with a net profit of 5.289 billion billion yuan in the same period last year. During the reporting period, the company's production performance continued to improve, and breeding costs continued to decrease. However, due to the significant year-on-year decline in pig sales prices, the decline in product prices was greater than the decline in breeding costs, and the company's pig breeding business suffered a deep loss.

jingke energy performance express: 2023 net profit of 7.486 billion yuan increased 154.97 year on year

JinkoSolar (688223) released a performance bulletin on the evening of February 27, with total operating income of 118.682 billion billion yuan in 2023, up 43.55 percent from a year earlier; net profit of 7.486 billion billion yuan, up 154.97 percent from a year earlier; and basic earnings per share of 0.75 yuan. During the reporting period, the company relied on the continuous leadership of N-type TOPCon technology and products, as well as the advantages of global operations and integrated production capacity, to achieve rapid volume of N-type component shipments, driving a significant increase in operating performance over the same period last year.

furande performance express: 2023 net profit of 0.417 billion yuan increased by 36.78 year on year

Fulande (605050) released a performance bulletin on the evening of February 27, with total operating income of 9.779 billion yuan in 2023, down 5.44 percent from the same period last year; net profit of 0.417 billion yuan, up 36.78 percent from the same period last year; and basic earnings per share of 0.84 yuan. During the reporting period, the company's end-user sales accounted for an increase compared to the same period last year, and the gross profit margin of end-user sales was higher. Therefore, the company's net profit in 2023 increased more than the same period last year.

Bailong Chuangyuan Performance Express: 2023 Net Profit 0.193 billion Yuan Increases 27.97 Year-on-Year

Bailong Chuangyuan (605016) released a performance bulletin on the evening of February 27, with total operating income of 0.868 billion yuan in 2023, up 20.28 percent from the same period last year; net profit of 0.193 billion yuan, up 27.97 percent from the same period last year; and basic earnings per share of 0.78 yuan. During the reporting period, the growth of domestic and foreign customer demand led to an increase in the sales volume of the company's products; the company's "annual output of 20000 tons of functional sugar drying project" was put into operation, and the release of production capacity led to an increase in sales volume and revenue.

Jinshan office performance bulletin: 2023 net profit of 1.319 billion yuan increased 18.03 year on year

Jinshan Office (688111) released a performance bulletin on the evening of February 27, with total operating income of 4.556 billion billion yuan in 2023, up 17.27 percent from a year earlier; net profit of 1.319 billion billion yuan, up 18.03 percent from a year earlier; and basic earnings per share of 2.86 yuan. During the reporting period, the company launched a one-stop smart office platform WPS365. Under the trend of dual optimization of products and services, it effectively improved the digital and intelligent office experience of government and enterprise customers, and promoted the rapid growth of domestic institutional subscription and service business. During the reporting period, it achieved revenue of about 0.957 billion yuan, a year-on-year increase of about 38.36.

sun paper performance express: net profit in 2023 increased by 9.38 year on year

Sun Paper (002078) released a performance bulletin on the evening of February 27, achieving total operating income of 39.703 billion billion yuan in 2023, a year-on-year decrease of 0.16; net profit of 3.072 billion billion yuan, a year-on-year increase of 9.38; basic earnings per share of 1.10 yuan.

changjiang securities performance express: 2023 net profit increased by 2.58 year on year

changjiang securities (000783) released a performance bulletin on the evening of February 27, achieving a total operating income of 6.896 billion billion yuan in 2023, an increase of 8.23 year-on-year; net profit 15.48Billion yuan, up 2.58 year-on-year; Basic earnings per share were 0.26 yuan.

qiaqia Food Performance Express: Net Profit Decreased 17.5 Year on Year in 2023

qiaqia food (002557) released its performance bulletin on the evening of February 27. In 2023, the total operating income was 6.806 billion billion yuan, down 1.13 percent from the same period last year; the net profit was 0.805 billion billion yuan, down 17.5 percent from the same period last year; and the basic earnings per share was 1.59 yuan. During the reporting period, the company's e-commerce through the sound, spell a lot and other channels, continue to make breakthroughs, overseas markets continue to cultivate the Southeast Asian market, channels continue to penetrate and deepen, the overall sales have a recovery growth.

tianci material performance express: net profit in 2023 decreased by 66.61 year on year

Tianci Materials (002709) released a performance bulletin on the evening of February 27, achieving total operating income of 15.506 billion billion yuan in 2023, down 30.52 percent from the same period last year; net profit of 1.908 billion billion yuan, down 66.61 percent from the same period last year; and basic earnings per share of 1.00 yuan. The main reasons for the decline in performance are: the decrease in gross profit per unit of electrolyte products leads to a decrease in profits; The new production capacity of positive electrode material precursor iron phosphate products is slowly climbing, and the overall profitability of the business is not as expected in the face of the continuous decline in market prices. Under the influence of the market environment, the company's provision for inventory depreciation of lithium carbonate and positive electrode material iron phosphate has increased.

[The winning contract]

China construction: recently obtained a total of 33.16 billion yuan for several major projects

China construction (601668) announced on the evening of February 27 that the company has recently obtained a number of major projects with a total amount of 33.16 billion yuan, accounting for 1.6 of the company's audited operating income in 2022.

Pudong construction: subsidiary won the bid for a total of 2.042 billion yuan project

Pudong construction (600284) announced on the evening of February 27 that Pujian group, a wholly-owned subsidiary of the company, won the bid for two projects through public bidding, namely, the apartment hotel and commercial project project of the J9A-05 plot above Jinqiao subway, and the apartment hotel and commercial project of the J9A-06 plot above Jinqiao subway. The total bid price of the above two projects is 2.042 billion yuan, accounting for about 14.5 of the company's total audited operating income in 2022.

tongding interconnection: winning the bid for the centralized procurement project of China iron tower of about 0.437 billion yuan

tongding interconnection (002491) announced on the evening of February 27 that the company recently received the "bid winning notice" from Jiangsu zhongbo communication co., ltd., a bidding agency entrusted by China tower, confirming that the company is the bid winning unit of "China tower 2024 feeder product centralized procurement project". the bid winning amount is about 0.437 billion yuan (excluding tax), accounting for 39.03 of the total sales of audited similar products in 2022, 13.19 percent of operating income in 2022.

Han Jianhe Shan: Signed two pipe purchase contracts

Han Jianhe Mountain (603616) announced on the evening of February 27 that Wanjiazhai Water Company and Han Jianhe Mountain signed a pipe purchase contract with a contract amount of 0.118 billion yuan (including tax). Han Jianhe Mountain announced on the same day that Wanjiazhai Water Company signed a pipe purchase contract with a consortium of Han Jianhe Mountain and Shanxi Water Construction Pipe Industry Co., Ltd., with a contract amount of 0.141 billion yuan (including tax).

[Major investment]

Central Hailu: wholly-owned subsidiary shares in Stararrow Sky by way of capital increase

Central Hailu (301040) announced on the evening of February 27 that Beijing Honggen Hehe Technology Development Co., Ltd. (hereinafter referred to as "Honggen Hehe"), a wholly-owned subsidiary of the company, used its own capital of 30 million yuan to participate in Beijing Xingjian Changkong Measurement and Control Technology Co., Ltd. (hereinafter referred to as "Xingjian Changkong"). Xingjian Changkong is a high-tech enterprise focusing on the research and development and production of accelerometers, the core components of inertial navigation system, after the completion of this capital increase, the proportion of shares held by Honggen Hehe in Xingjian Changkong is 8.8235.

[Other]

Bairun shares: Chairman Liu Xiaodong was personally investigated and detained for suspected bribery

Bairun shares (002568) announced on the evening of February 27 that the company recently received a notice issued by the Nanzheng District Supervisory Committee of Hanzhong City regarding the personal investigation and retention of Liu Xiaodong, chairman, legal representative and general manager of the company, on suspicion of bribery. As of the disclosure date of the announcement, the control right of the company has not changed. All directors, supervisors and senior managers of the company except Liu Xiaodong perform their duties normally, and the production, operation and management of the company are normal. The above matters will not have a significant impact on the normal production and operation of the company.

cool intelligence: the matters filed for investigation by the securities regulatory commission have nothing to do with the company

cool intelligence (300840) announced on the evening of February 27 that the company received a notice from Zhang Yan, the person acting in concert with the actual controller, that Zhang Yan received a notice of filing a case issued by the CSRC on February 26. for suspected illegal insider trading, according to relevant laws and regulations, the CSRC will decide to file a case against it. After the implementation of the company and Zhang Yan, this case is an investigation against Zhang Yan. The matter under investigation has nothing to do with the company and will not have a significant impact on the company's daily operation.

Shanghai yi lian (rights protection): filed by CSRC for suspected violation of letter and disclosure

Shanghai Yilian (600836) announced on the evening of February 27 that the company received a notice of filing a case from the CSRC on February 27. Due to the company's suspected information disclosure violations, in accordance with relevant laws and regulations, the China Securities Regulatory Commission decided to file a case against the company. At present, the company's production and business activities are carried out normally.

haoli technology: the actual controller was filed by the securities and futures Commission on suspicion of violating the law and regulations.

Haoli Technology (002729) announced on the evening of February 27 that Tang Qiqing, the actual controller and director of the company, received the notice of filing a case issued by the China Securities Regulatory Commission. On suspicion of information disclosure violations, the China Securities Regulatory Commission decided to file a case against Tang Qiqing. At present, the company's daily production and operation activities are carried out normally.

Rhine biological (rights): signed industrial hemp atomization project cooperation agreement

Rhine Biology (002166) announced on the evening of February 27 that the company signed a three-year "Project Cooperation Agreement" with natural person Chen Hao and his team. The two sides will jointly reach a close cooperative relationship on the construction and development of industrial hemp atomization terminal products and oil injection solution service brand. The company or its holding subsidiary will set up two companies to carry out project cooperation with Chen Hao and his team, and the two sides will make every effort to promote these companies to become leading brands in the industrial hemp atomization industry. and add new momentum to the company's business development and investment layout in the field of industrial hemp.

Menglily: U.S. Department of Commerce mattress anti-dumping duty investigation has not caused significant adverse impact on the company's production and operation

dream lily (603313) announced on the evening of February 27 that recently, the U.S. Department of Commerce announced a preliminary affirmative ruling on the anti-dumping duty investigation of mattresses from 12 countries or regions. the preliminary ruling of this anti-dumping duty investigation involves the company's Spanish production base hengkang Spain, COMOTEX and Thailand production bases in Thailand. According to the preliminary ruling released by the U.S. Department of Commerce, Hengkang Spain and COMOTEX are taxed at 10.74 percent. Although Ligao Thailand is a compulsory respondent company, it no longer exports anti-dumping products to the United States, so it did not participate in the response this time. The anti-dumping duty investigation covers some of the thick mat products produced by the Spanish production base and exported to the United States, and the thin mat products and other household products produced by the Spanish production base and exported to the United States are not included. The US Department of Commerce released the preliminary results of the anti-dumping duty investigation. At present, the anti-dumping duty investigation has not yet been completed, and a final ruling will be made after further investigation by the US Department of Commerce. The company has laid out its production capacity in the United States, and this anti-dumping has not had a significant adverse impact on the company's production and operation.

Foton Motor: Received 0.104 billion yuan National New Energy Vehicle Promotion Subsidy

Futian Motor (600166) announced on the evening of February 27 that the company recently received a new energy vehicle promotion subsidy of 0.104 billion yuan from the Beijing Municipal Finance Bureau, which is the subsidy fund for the promotion and application of new energy vehicles in 2021-2022. The new energy vehicle promotion subsidy received this time will not affect the current profit, and will directly reduce the company's new energy subsidy receivable, which will have a positive impact on the company's cash flow and reduce the capital occupation.

Shandong Expressway: Chairman Sai Zhiyi Resigns for Work Reasons

Shandong Expressway (600350) announced on the evening of February 27 that Sai Zhiyi, chairman and director of the company, applied to resign as chairman and director of the sixth board of directors of the company due to work reasons. After resigning from the above position, Sai Zhiyi will no longer hold any position in the company.

Hengrui Pharmaceuticals: subsidiary received notice of drug clinical trial approval

Hengrui Pharmaceutical (600276) announced on the evening of February 27 that the company's subsidiaries Shanghai Shengdi Pharmaceutical Co., Ltd. and Suzhou Shengdiya Biopharmaceutical Co., Ltd. received the approval of the State Food and Drug Administration to issue the drug clinical trial approval notice for adeselizumab injection and SHR-A1811 for injection, and clinical trials will be carried out in the near future.

ANGLIKANG: Subsidiary Obtain Veterinary Drug Product Approval No.

anglikang (002940) announced on the evening of February 27 that Zhejiang anglikang animal protection technology co., ltd., a subsidiary of the company, recently received the approval document of "cimetidine tablets (for pets)" veterinary drug product approval issued by the Ministry of agriculture and rural areas.

HISSCO: Subsidiary Obtain Notification of Approval for Clinical Trial of Innovative Drug HSK39775 Tablets

Cisco (002653) announced on the evening of February 27 that Tibet Cisco Pharmaceutical Co., Ltd., a subsidiary of the company, recently received the HSK39775 tablet "Drug Clinical Trial Approval Notice" issued by the State Food and Drug Administration. HSK39775 tablet is a brand-new drug with independent intellectual property rights for the treatment of advanced solid tumors developed by the company.

Step Pharmaceuticals: Holding subsidiary received notice of drug clinical trial approval

Buchang Pharmaceuticals (603858) announced on the evening of February 27 that Luzhou Buchang, the company's controlling subsidiary, has obtained the approval of the State Drug Administration for the clinical trial application for the new indication of "BC001 for Injection" under development and received the notice of approval for the drug clinical trial. The proposed indication is BC001 combined with PD-1 monoclonal antibody for the treatment of advanced or metastatic solid tumors, including but not limited to BC001 in combination with xindiliximab plus XELOX as first-line treatment for HER-2 negative advanced or metastatic gastric or gastroesophageal junction adenocarcinoma (GC/GEJ).

Fuyuan Pharmaceutical: Cilostazol Tablets Obtain Drug Registration Certificate

fuyuan medicine (601089) announced on the evening of February 27 that the company recently received the drug registration certificate of cilostazol tablets (specification: 50mg) issued by the state drug administration. Cilostazol tablets are used to improve ischemic symptoms such as ulcers, limb pain, cold sensation and intermittent claudication caused by chronic arterial occlusive disease, and to prevent recurrence of cerebral infarction (excluding cardiogenic cerebral infarction).

Zhongsheng Pharmaceuticals: Phase II clinical trial of a subsidiary of a class of innovative drug RAY1225 injection for patients with type 2 diabetes mellitus completed the first subject enrollment

Zhongsheng Pharmaceutical (002317) announced on the evening of February 27 that a class of innovative polypeptide drug RAY1225 injection independently developed by Zhongsheng Ruichuang, the company's holding subsidiary, has been launched in February 2024 for type 2 diabetes and Two phase II clinical trials for overweight/obese patientsThe first subjects who recently completed a Phase II clinical trial for type 2 diabetes were enrolled.